pifithrin has been researched along with Liver Cirrhosis in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, H | 1 |
| Lian, N | 1 |
| Zhang, F | 1 |
| Chen, L | 1 |
| Chen, Q | 1 |
| Lu, C | 1 |
| Bian, M | 1 |
| Shao, J | 1 |
| Wu, L | 1 |
| Zheng, S | 1 |
1 other study available for pifithrin and Liver Cirrhosis
| Article | Year |
|---|---|
Activation of PPARĪ³/P53 signaling is required for curcumin to induce hepatic stellate cell senescence.
Topics: Animals; Benzothiazoles; Cell Cycle Checkpoints; Cell Proliferation; Cellular Senescence; Curcumin; | 2016 |